2,2',3,5',6-pentachlorobiphenyl and Disease Models, Animal

2,2',3,5',6-pentachlorobiphenyl has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pessah, IN; Ta, TA	1

Other Studies

1 other study(ies) available for 2,2',3,5',6-pentachlorobiphenyl and Disease Models, Animal

Article	Year
Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95). Neurotoxicology, 2007, Volume: 28, Issue:4 Topics: Animals; Arginine; Calcium; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; In Vitro Techniques; Inhibitory Concentration 50; Malignant Hyperthermia; Muscle, Skeletal; Mutation; Polychlorinated Biphenyls; Protein Binding; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Swine; Tritium	2007

Article

Year

Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).

Neurotoxicology, 2007, Volume: 28, Issue:4

Topics: Animals; Arginine; Calcium; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; In Vitro Techniques; Inhibitory Concentration 50; Malignant Hyperthermia; Muscle, Skeletal; Mutation; Polychlorinated Biphenyls; Protein Binding; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Swine; Tritium

2007